HCC Manager LLC
CIK
1844818
Location
Chicago, IL
Portfolio Value
Micro
$10,282,514
Diversification
Highly concentrated
Filing Date
Global Rank
#7,956
/ 8,420
▼ 266
Top Industry
Biotechnology
100.0%
3Y Alpha vs SPY
-83.1%
Period ended 5 months ago
Filed Feb 10, 2026 · 4mo
8 quarters · since Mar 2024
Clone Performance
May 2024–Jun 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
-88.1%
SPY
+43.4%
Annualised alpha
-83.1%
Max drawdown
−94.8%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
1 positions · as of Dec 31, 2025 · Δ vs Sep 30, 2025Top Position
100.0%
0.0 pts
Top 5
100.0%
0.0 pts
Top 10
100.0%
0.0 pts
HHI
10,000
Highly concentrated0
Portfolio Trend
8 quarters · across all stocks
Sector Breakdown
As of Dec 31, 2025| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $10,282,514 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increasedNo qualifying positions this quarter.
Trimmed
Positions the filer reduced
1 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| GUTS | Fractyl Health, Inc. | −1 | 4,673,870 | $10,282,514 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarterNo qualifying positions this quarter.
Sold Out
Positions the filer fully exitedNo qualifying positions this quarter.
1 positions ·
$10,282,514 total
· as of Dec 31, 2025
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| GUTS |
Fractyl Health, Inc.
Healthcare
|
Reduced | 4,673,870 | $10,282,514 | 100.00% |